Status:
COMPLETED
Sufentanil on Anesthesia Introduction and Recovery Quality in Pediatric Adenotonsillectomy
Lead Sponsor:
Tongji Hospital
Conditions:
Sufentanil
Eligibility:
All Genders
1-12 years
Phase:
NA
Brief Summary
To study the effect of different doses of sufentanil on anesthesia induction and analgesia after tonsillectomy in children. According to the different doses of sufentanil used in anesthesia induction,...
Detailed Description
Fifteen minutes before operation, midazolam 0.1 mg/kg was slowly intravenously injected. Five minutes later, the child entered the operating room. Pi, Narcotrend, blood pressure, ECG, SpO2 and body te...
Eligibility Criteria
Inclusion
- Age 1-12 years,
- ASA I-II grade;
- selective adenotonsillectomy
- BMI 18.5～23.9,
- Sign informed consent
Exclusion
- Emergency surgery;
- Abnormal liver and kidney function
- severe dehydration and malnutrition or Hb \< 10g/dl;
- BMI \<18.5 or \<23.9;
- Children with neurological disorders
Key Trial Info
Start Date :
July 6 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2022
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04067648
Start Date
July 6 2020
End Date
December 18 2022
Last Update
January 10 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tongji Hospital
Wuhan, Hubei, China, 430000